Menu

Federal Contractor Misconduct Database (FCMD)

The federal government routinely awards contracts to companies with histories of misconduct, including contract fraud and other violations. POGO believes that providing this website will help to improve contracting decisions and increase public knowledge of how the government spends billions of taxpayer dollars each year. Read more…

Fraudulent Pricing of Anzemet

Aventis Pharmaceuticals Inc. agreed to pay $190,433,326 “to resolve allegations that the company caused false claims to be filed with Medicare and other federal health programs as a result of the company’s alleged fraudulent pricing and marketing of drugs.” The case involved the pricing between 1997 and 2004 of Anzemet, a treatment given to cancer patients after chemotherapy. The government alleged Aventis engaged in a scheme to set fraudulent and inflated prices for Anzemet knowing that federal health care programs established reimbursement rates based on those prices. The settlement will be split between the federal government and the governments of several states and the District of Columbia.

Misconduct Type
Health
Enforcement Agency
Health and Human Services
Contracting Party
None
Court Type
Civil
Disposition
Settlement
Date of Announcement
9/10/2007
Contractors Involved Penalty
Total
Sanofi-Aventis $190,433,326
Further Information Released
DOJ Press Release 9/12/2007

Federal Contractor Misconduct Database